Showing results (571-580 of 739) with videos related to

Sort By:
Pageof 74
Leukemia|May 21, 2010
Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remissionR B Walter, J M Pagel, T A Gooley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2010
High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology groupRoland B Walter, Todd A Alonzo, Robert B Gerbing, et al.
Frontiers in Immunology|April 24, 2023
H3N2 influenza hemagglutination inhibition method qualification with data driven statistical methods for human clinical trialsSheetal Sawant, Sarah Anne Gurley, R Glenn Overman, et al.
Aquatic Toxicology (Amsterdam, Netherlands)|January 12, 2010
Silver nanospheres are cytotoxic and genotoxic to fish cellsJohn Pierce Wise, Britton C Goodale, Sandra S Wise, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 23, 2021
Financial Implications of Early Hospital Discharge After AML-Like Induction Chemotherapy: A 4-Year Retrospective AnalysisNathan J Moore, Megan Othus, Anna B Halpern, et al.
Pediatrics|March 28, 2022
Safety of Live Attenuated Influenza Vaccine in Children With AsthmaAndrew G Sokolow, Amy P Stallings, Carolyn Kercsmar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2015
Multimerin-1 (MMRN1) as Novel Adverse Marker in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology GroupGeorge S Laszlo, Todd A Alonzo, Chelsea J Gudgeon, et al.
JAMA Oncology|May 9, 2024
Dose-Adjusted EPOCH Plus Inotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL: A Phase 1 Dose-Escalation TrialNoam E Kopmar, Kim Quach, Ted A Gooley, et al.
Journal of Cancer Research and Clinical Oncology|August 8, 2022
Improved preoperative risk stratification in endometrial carcinoma patients: external validation of the ENDORISK Bayesian network model in a large population-based case seriesMarcel Grube, Casper Reijnen, Peter J F Lucas, et al.
Science Translational Medicine|November 5, 2020
Antibody binding to native cytomegalovirus glycoprotein B predicts efficacy of the gB/MF59 vaccine in humansJennifer A Jenks, Cody S Nelson, Hunter K Roark, et al.
Pageof 74